ExiVex reports human pharmacokinetic data showing that intranasal naloxone EMRX-101 approaches peak plasma concentrations similar to IV with a significantly faster Tmax than the currently approved comparatorMay 15, 2026
ExiVex reports human pharmacokinetic data showing that intranasal naloxone EMRX-101 approaches peak plasma concentrations similar to IV with a significantly faster Tmax than the currently approved comparatorMay 15, 2026
Perioperative medicine is emerging as a system-wide strategy for better surgical outcomesMay 14, 2026
Folic acid before pregnancy may help reduce the risk of birth defects for women taking epilepsy drugsMay 10, 2026
News Significant global cardiovascular risk associated with high lipoprotein(a) levels.By healthtostSeptember 13, 20240The review in The Lancet finds that one in five people worldwide are at risk of heart disease because they…
